PathoQuest

PathoQuest is a biotechnology company identifying pathogens through High Throughput Sequencing (HTS).

Total raised

€19M

€19,464,000

Funding rounds

Investors

distinct backers

Active since

2013-06

latest 2021-11

Funding by year

EUR raised per year

High confidence

Raise-next likelihood20

base rate 48% for Series B

Exit likelihood13

base rate 12% (2+ rounds)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2021-11-10	Series B	€15M	Aurinvest,Charles River Laboratories,Eurazeo,Kurma Partners,Sham,SHS Capital+2 more	View deal →
2013-07-01	Other	€4.5M	IDInvest Partners	View deal →

same sector or country